|
Volumn 60, Issue 6, 2011, Pages 879-880
|
Kinase inhibitors in the treatment of chronic hepatitis C virus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ALPHA2A INTERFERON;
CORTICOSTEROID;
CYCLOSPORIN;
ERLOTINIB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RIBAVIRIN;
TACROLIMUS;
VIRUS RNA;
ADULT;
ALCOHOL CONSUMPTION;
ANEMIA;
BLOOD TOXICITY;
CASE REPORT;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FATIGUE;
GENOTYPE;
GRAFT VERSUS HOST REACTION;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
LIVER TRANSPLANTATION;
MALE;
METASTASIS;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
VIRUS LOAD;
ADULT;
ANTIVIRAL AGENTS;
FATAL OUTCOME;
FOLLOW-UP STUDIES;
HEPATITIS C, CHRONIC;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
PROTEIN KINASE INHIBITORS;
QUINAZOLINES;
|
EID: 79955853640
PISSN: 00175749
EISSN: 14683288
Source Type: Journal
DOI: 10.1136/gut.2010.212068 Document Type: Letter |
Times cited : (12)
|
References (4)
|